New Medical Device Stock in Our Cross Hairs
I hope you had a great start to your new year. In 2020, we are resolving to aggressively hunt, actively track and potentially buy superior medical device/testing companies with clear economic advantages over their peers. We have already identified one in which we have just initiated a position and intent to add to it. If it follows the overarching pattern of performance of the medical device stocks we have invested in over the years, we frankly think it will make a positive impact on our track record.
The Compelling Case For Medical Device Stocks
We find medical device companies through parameters that we think can increase their stocks' prices in multiples:
We believe our new finding meets all of the above criteria, which is why we took a position.
Our decisions to buy these stocks were based off the some of the same criteria above. As you can see, there are different open dates and holding periods. We even still own some of them. This is testament to our disciplines on investing in stocks that we have vetted and believe have outsized chances of performing well in the long term.
I want to stress that we did not selectively choose to disclose just the stocks that went on to perform well - these stocks do, in fact, encompass our complete coverage of medical device stocks.
Repro Med Sys. (KRMD)
KRMD makes and sells a home infusion drug delivery system that does not require electric power to operate. Some of the reasons we liked the company included:
Zynex, Inc. (ZYXI)
ZYXI designs, manufactures, and markets medical devices to treat chronic and acute pain. Some of the reasons we invested in the company included:
Semler Scientific (SMLR)
SMLR manufactures and markets products that assist healthcare providers to treat patients with chronic diseases. Some of the reasons we invested in the company included:
As we forge ahead into 2020, to celebrate our tenth medical device stock idea, we are offering you our first special of the year.
Instead of committing to one year at the regular rate of $480/yr ($40/month), I would like to offer you full access to GEOInvesting for 1 month for just a one-time non-recurring fee of $24.99.
If you've already paid for any special offer in the past, the fee you pay for this offer will be added to the previous fee you've paid and go towards a discounted annual price, our Legacy Rate of $299.99, if you decide to subscribe. And to make it easier for you to decide, that annual fee would also be non-recurring.
We seriously want you to join in our success of our new medical device idea, and all of our other ideas at GeoInvesting. We've built a great community and we'll continue to grow as the microcap space continues to heat up!
Since GeoInvesting’s inception in 2007, GeoInvesting has worked diligently to understand and benefit from working in areas that the Wall Street “crowd” has avoided – namely, high growth microcap stocks. This niche of the market, while mostly ignored by analysts and financial media, is still often quietly invested in by many well-known billionaires. We apply our own proprietary analysis in the space to find pockets of information arbitrage and unnoticed opportunities that have acted as the backbone for our investing success for over a decade. During this time, we've found over 20 stocks for our members that increased by a factor of at least 5x.
We help investors understand companies better by interviewing management teams, dissecting conference calls, interacting with our wide network of investors and scouring financial documents for hidden clues. We do all that for you, saving you time.
Maj has nearly 30 years of investing experience and manages the GeoInvesting Team on a daily basis to increase the opportunity pipeline and heighten the Company's awareness in the financial markets to intensify its market influence.
Just wanted to say thanks for the subscription. I've always been a really big fan of Geo's stuff and it was what initally got me into microcap investing.
~ Michael L.
I am glad that I was able to join GeoInvesting. Microcaps are one of the very few niches where a retail investor can do well, and your service looks sincere and solid.
~ Heiko N.
Geoinvesting is great! I pretty much check it daily to see what's going on in the market and have awareness of many more microcap companies as a result.
~ Andrew G.
Offer EXPIRES January 17, 2019
Start 2020 with the kind of medical device stock idea that has historically provided out-sized returns for GeoInvesting members.
One-time payment of $24.99.
*Although this payment is non-refundable, the good news is that it can be applied to a signicantly discounted full year non-recurring membership at the end of the 1 month period. Just inquire after the month is over (or contact us now), and you'll get all the great details.
Sincerely,
Maj Soueidan Co-founder GeoInvesting, LLC
©2019 GeoInvesting, LLC. All Rights Reserved.
We are strictly a financial publisher and research boutique and do not provide personalized trading or investment advice. We publish information regarding stocks, options, futures, commodities, currencies or any other securities in which we believe our subscribers may be interested and our reports reflect our sincere opinions. These opinions comprise the basis of our research and may culminate in content that includes, but is not limited to “GeoBargain(s)”, “GeoNugget(s)”, “Reasons For Tracking (RFT)”, “Model or Mock Portfolios”, “Emails”, “Stock Screens”, “Calls to Action (CTA)”, “Selected Disclosures”, “Long Positions”, “Short Positions” (collectively herein referred to as “Premium Research”). The information and research on stocks listed in our disclosures or selected disclosures are intended to be for educational and information purposes only.
Nothing contained on this website should be considered investment advice, an offer to sell, or a solicitation of an offer to buy any security, nor shall GeoInvesting offer, sell or buy any security to or from any person through this site or reports on this site. GeoInvesting, LLC is not registered as an investment advisor in any jurisdiction. The content and materials contained on this website are provided for information purposes only and nothing contained therein is investment advice nor should it be construed as such. Prior to making any investment or subscribing to any of GeoInvesting’s free or premium services and products, you should consult with professional financial, legal and tax advisors to assist in due diligence as may be appropriate in determining the appropriateness of the risk associated with a particular investment.